BAXTER INTERNATIONA (BTL HM) stock market data APIs
€19.7858
0.14(0.7%)
as of September 17, 2025
Try our APIs with
free plan!
BAXTER INTERNATIONA Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BTL.HM.
Prev. Close
19.7858
Open
19.924
High
19.924
Low
19.7858
52 wk Range
18.8684-34.5335
Market Cap
35 849 M
Dividends (Yield)
0.0085
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BAXTER INTERNATIONA data using free add-ons & libraries
Get BAXTER INTERNATIONA Fundamental Data
BAXTER INTERNATIONA Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BAXTER INTERNATIONA News
New
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring
Baxter's Welch Allyn Connex 360 Vital Signs Monitor Designed for optimized workflows to support earlier detection of patient deterioration Future-ready device features customizable configurations and...
Opportunities in the Home Infusion Therapy Market 2025-2035 Featuring Strategic Analysis of Baxter International, B. Braun Melsungen, Fresenius Kabi, Medtronic, Terumo and More
Company Logo The market offers opportunities through increasing adoption due to rising chronic diseases, telehealth integration, and technological advancements. However, reimbursement challenges pers...
Does Surgeon-Led Hemopatch Launch Mark a New Innovation Edge for Baxter (BAX)?
On August 18, 2025, Baxter International unveiled its new Hemopatch sealing hemostat, a room-temperature collagen pad tailored for use in both open and minimally invasive surgeries, following a decade...
Is Baxter’s Sell-off an Opportunity for Long-Term Investors?
Baxter International Inc. (NYSE:BAX) is one of the most undervalued and overlooked large-cap stocks. On August 4, a Barclays analyst lowered his price target on Baxter International Inc. (NYSE:BAX) to...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
